Detalhe da pesquisa
1.
PD-1 receptor outside the main paradigm: tumour-intrinsic role and clinical implications for checkpoint blockade.
Br J Cancer
; 129(9): 1409-1416, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37474722
2.
International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer.
Ann Oncol
; 33(1): 57-66, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34624497
3.
Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016.
Ann Oncol
; 29(12): 2288-2295, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30304498
4.
Efficacy and safety of everolimus treatment in a hemodialysis patient with metastatic atypical bronchial carcinoid: case report and literature review.
BMC Cancer
; 18(1): 311, 2018 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29558899
5.
Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66].
Ann Oncol
; 33(4): 454, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086737
6.
Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome?
J Endocrinol Invest
; 39(4): 465-71, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26694705
7.
Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer.
Ann Oncol
; 26(3): 497-504, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25395283
8.
The prognostic role of baseline CEA and CA 19-9 values and their time-dependent variations in advanced colorectal cancer patients submitted to first-line therapy.
Tumour Biol
; 36(3): 1519-27, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25374062
9.
Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study.
ESMO Open
; 9(1): 102202, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38118368
10.
Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer.
Ann Oncol
; 24(1): 59-66, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22887466
11.
Consensus clustering methodology to improve molecular stratification of non-small cell lung cancer.
Sci Rep
; 13(1): 7759, 2023 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173325
12.
Zoledronic acid in patients with stage IIIA/B NSCLC: results of a randomized, phase III study.
Ann Oncol
; 23(8): 2082-2087, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22730101
13.
Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer.
Ann Oncol
; 23(7): 1723-9, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22186609
14.
A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer.
Ann Oncol
; 22(3): 553-558, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20696676
15.
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis.
Ann Oncol
; 22(10): 2277-85, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21325444
16.
Tivantinib added to erlotinib in nonsmall-cell lung cancer: the primary end point was not MET....
Ann Oncol
; 26(10): 2007-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26265168
17.
Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer.
Ann Oncol
; 21(3): 556-561, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19828561
18.
Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer.
Br J Cancer
; 101(9): 1543-8, 2009 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-19826424
19.
Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment.
Gynecol Oncol Rep
; 28: 44-46, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30859116
20.
Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification.
Eur Respir J
; 38(2): 239-43, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21804158